Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

279
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
279
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

657
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
657
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.3K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.3K
Determination of Renal Drug Clearance: Graphical and Midpoint Methods01:07

Determination of Renal Drug Clearance: Graphical and Midpoint Methods

442
Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
442
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

370
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
370
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

658
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
658

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same author

An Ether-Containing Hafnium-Diethylene Glycol Dry Resist Prepared by Molecular Layer Deposition for Mild-Acid Development.

Nanomaterials (Basel, Switzerland)·2026
Same author

Perturbing glycosylphosphatidylinositol (GPI)-anchor biosynthesis alters cell wall architecture and modulates fungal morphology.

bioRxiv : the preprint server for biology·2026
Same author

Mycoelectronics: Bioprinted living fungal bioelectronics for artificial sensation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

CXCL8 Enhances Malignancy of GBM via TNFα-NFκB Mediated Suppression of Ferroptosis.

Applied biochemistry and biotechnology·2026
Same author

Tuning *OH Oxidativity via a Cu-Co(OH)<sub>2</sub> Cocatalyst on a Hematite Photoanode for Selective Cyclohexanone Oxidation.

Journal of the American Chemical Society·2026
Same journal

Different Clinical Questions Need Different Estimands.

Therapeutic innovation & regulatory science·2026
Same journal

Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough.

Therapeutic innovation & regulatory science·2026
Same journal

Understanding the Added Value of Action Limits for QTL Monitoring.

Therapeutic innovation & regulatory science·2026
Same journal

Implementing Project Optimus in Oncology Dosage Optimization: Where are We Now?

Therapeutic innovation & regulatory science·2026
Same journal

Validation of the Ontario Protocol Assessment Level (OPAL) Tool for Assessing Clinical Trial Complexity and Supporting Workforce Planning in the Italian Clinical Research Context.

Therapeutic innovation & regulatory science·2026
Same journal

The Effect of Covariate Adjustment for Cox Regression in Cardiovascular Outcome Trials.

Therapeutic innovation & regulatory science·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Feb 26, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

874

Desarrollo del Marco de Estimación para la Estimación de la Pendiente de eGFR y Análisis Comparativos a Través de

Tuo Wang1, Yu Du2

  • 1Global Statistical Sciences, Eli Lilly and Company, Indianapolis, Indiana, USA. tuo.wang@lilly.com.

Therapeutic innovation & regulatory science
|February 25, 2026
PubMed
Resumen
Este resumen es generado por máquina.

Se propone un marco estandarizado para estimar la pendiente de la tasa de filtración glomerular estimada (eGFR) para mejorar los resultados de los ensayos clínicos de enfermedad renal crónica (ERC). Este enfoque mejora la fiabilidad y la comparabilidad del desarrollo terapéutico de la ERC.

Palabras clave:
pendiente de eGFREstimandoEnfermedad renal crónicaModelos de efectos mixtosPunto final sustituto

Más Videos Relacionados

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.7K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K

Videos de Experimentos Relacionados

Last Updated: Feb 26, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

874
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.7K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K

Área de la Ciencia:

  • Nefrología
  • Ensayos Clínicos
  • Bioestadística

Sus antecedentes:

  • La enfermedad renal crónica (ERC) representa una carga sanitaria mundial, y la progresión a la enfermedad renal terminal (ERT) conduce a un aumento de la mortalidad.
  • Los puntos finales compuestos renales tradicionales en los ensayos de ERC requieren largos períodos de seguimiento.
  • La pendiente de la tasa de filtración glomerular estimada (eGFR) es un valioso punto final sustituto para la disminución de la función renal, pero carece de métodos de estimación estandarizados.

Objetivo del estudio:

  • Proponer un marco de estimación novedoso para análisis basados en la pendiente de eGFR en ensayos controlados aleatorizados (ECA) de ERC.
  • Mejorar la claridad en la definición de los estimandos y mejorar la comparabilidad de los resultados entre los ensayos de ERC.
  • Evaluar el rendimiento de varias técnicas de estimación para la pendiente de eGFR en diferentes escenarios.

Principales métodos:

  • Desarrollo de un marco de estimación a medida para la pendiente de eGFR en ECA de ERC.
  • Realización de estudios de simulación para evaluar las técnicas de estimación.
  • Aplicación de métodos a datos de pacientes con ERC del mundo real.

Principales resultados:

  • El marco propuesto proporciona una definición clara para los estimandos de la pendiente de eGFR.
  • La evaluación identificó enfoques de estimación adecuados, particularmente para escenarios con bajas tasas de eventos competitivos.
  • El estudio destaca la importancia de alinear los métodos de estimación con los objetivos específicos del ensayo.

Conclusiones:

  • Un marco de estimación estandarizado es crucial para análisis fiables e interpretables de la pendiente de eGFR en ensayos de ERC.
  • Este trabajo avanza en el desarrollo terapéutico al mejorar la consistencia de los resultados de los ensayos de ERC.
  • Los hallazgos respaldan una mejor toma de decisiones clínicas en el manejo de la enfermedad renal crónica.